Esomeprazole reduces gastric and duodenal ulcer development among high risk NSAID users

Scheiman*, J M; Yeomans, N; Hawkey, C J; Talley, N J; Gothe, L; Sung, J; Jones, R; Naesdal, J
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS52
Academic Journal
An abstract of the article "Esomeprazole Reduces Gastric and Duodenal Ulcer Development Among High Risk NSAID Users," by J.M. Schieman and colleagues is presented.


Related Articles

  • Unreviewed Reports. Mellem, H.; Stave, R.; Janke, P.G.; O'Donoghute, D.J.; Philpps, J.H.; Borslen, S.; Kingxim, J.C.P.; Keeling, P.; Harronen, Mauno // British Medical Journal (Clinical Research Edition);6/1/1985, Vol. 290 Issue 6482, p1628 

    Presents several unreviewed reports on medicine as of June 1985. Effect of non-steroidal anti-inflammatory drugs on ulcer symptoms; Examination on the occurrence of pseudohypoparathyroidism in identical twins; Risk of bilateral retinal attachment on pregnant women with induced hypertension.

  • Duodenal and Gastric Ulcer Prevention with Misoprostol in Arthritis Patients Taking NSAIDs. Graham, David Y.; White, Richard H.; Moreland, Larry W.; Schubert, Timothy T.; Katz, Robert; Jaszewski, Richard; Tindall, Elizabeth; Triadafilopoulos, George; Stromatt, Scott C.; Teoh, Leah S. // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p257 

    Features a study that determined the efficacy of misoprostol for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced duodenal and gastric ulcers in arthritis patients receiving NSAID therapy. Percentage of evaluable and intent-to-treat patients with duodenal ulcers; Percentage...

  • Can Gastroduodenal Ulcers In NSAID Users Be Prevented? Feldman, Mark // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p337 

    Editorial. Focuses on the prevention of gastroduodenal and intestinal ulcers in users of non-steroidal anti-inflammatory drugs (NSAID). Clinical trials on the protective effect of misoprostol on gastroduodenal ulcers; Identification of a high risk group of NSAID users.

  • Bleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area. O'Brien, J.D.; Burnham, W.R. // British Medical Journal (Clinical Research Edition);12/7/1985, Vol. 291 Issue 6509, p1609 

    Examines the use of non-steroidal anti-inflammatory drugs in bleeding peptic ulcer in Romford, England. Administration of electrocoagulation in the treatment of ulcer; Interrelation between piroxicam drug administration and gastrointestinal hemorrhage; Consideration on the prescribing frequency...

  • Non-steroidal anti-inflammatory drugs and peptic ulcers. Hawkey, C.J. // BMJ: British Medical Journal (International Edition);2/3/90, Vol. 300 Issue 6720, p278 

    Examines the association between non-steroidal anti-inflammatory drugs (NSAIDS) and peptic ulceration in the elderly. Consistency of upper gastrointestinal bleeding in aspirin use; Vagueness in the ability of NSAIDS to induce duodenal ulcer; Comparison between NSAID-induced ulcers and ulcers...

  • Spice It Up! Dunkin, Mary Anne // Arthritis Today;Jan/Feb99, Vol. 13 Issue 1, p13 

    Focuses on the cause of nonsteroidal anti-inflammatory drug (NSAID) -related stomach upset and ulcers. Fallacy about the problem.

  • Risk of ulcers from NSAIDs is varied. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p19 

    States that epidemiologic studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) vary in their ability to cause ulcers. Difficulty of comparing equipotent doses; Ibuprofen; Risk factors.

  • Helicobacter pylori eradication reduced the risk for ulcers in dyspeptic patients who were about to begin NSAID treatment. van Zanten, Sander J.O. Veldhuyzen // ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p13 

    Provides information on a study that explored whether the eradication of Helicobacter pylori infection reduce the risk for ulcers in patients who have H. pylori and dyspepsia or a history of ulcer and who are about to begin nonsteroidal anti-inflammatory drug treatment. Study design and...

  • Some NSAIDS have higher risk of ulcer bleeding than others.  // Geriatrics;Dec94, Vol. 49 Issue 12, p58 

    Summarizes Weil Langman's `Risks of Bleeding Peptic Ulcer Associated With Individual Nonsteroidal Anti-Inflammatory Drugs,' published in the `Lancet' in 1994. Effects of nonsteroidal anti-inflammatory drugs (NSAIDS) on peptic ulcer conditions; Clinical strategies for the prevention of peptic...

  • Famotidine is effective therapy for NSAID-associated ulceration. Hudson, N.; Taha, A.S. // Geriatrics;Sep97, Vol. 52 Issue 9, p105 

    Reports the effectivity of H2 antagonist famotidine in healing non-steroidal-anti-inflammatory-drug (NSAID) associated ulceration of gastroduodenal according to the study in Great Britain. Ulcer healing rates for groups studied; Tolerance of patients for famotidine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics